DNMT3A and acute myeloid leukemia: Additionally, Guryanova et al. [10,32] showed recently that DNMT3A cooperates with FLT3-ITD and NPM1 to induce AML in vivo, and promotes resistance to anthracycline chemotherapy through impaired nucleosome eviction and chromatin remodeling in response to anthracyclines.